129 related articles for article (PubMed ID: 22293874)
21. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
[TBL] [Abstract][Full Text] [Related]
22. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density.
Ash L; Teknos TN; Gandhi D; Patel S; Mukherji SK
Radiology; 2009 May; 251(2):422-8. PubMed ID: 19276321
[TBL] [Abstract][Full Text] [Related]
23. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
[TBL] [Abstract][Full Text] [Related]
24. Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.
Truong MT; Saito N; Ozonoff A; Wang J; Lee R; Qureshi MM; Jalisi S; Sakai O
AJNR Am J Neuroradiol; 2011 Aug; 32(7):1195-201. PubMed ID: 21757530
[TBL] [Abstract][Full Text] [Related]
25. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
26. Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview.
Evangelista L; Cervino AR; Chondrogiannis S; Marzola MC; Maffione AM; Colletti PM; Muzzio PC; Rubello D
Nucl Med Commun; 2014 Feb; 35(2):123-34. PubMed ID: 24220055
[TBL] [Abstract][Full Text] [Related]
27. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma.
Akoğlu E; Dutipek M; Bekiş R; Değirmenci B; Ada E; Güneri A
J Otolaryngol; 2005 Dec; 34(6):384-94. PubMed ID: 16343398
[TBL] [Abstract][Full Text] [Related]
28. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
29. [The extracapsular spread of cervical lymph node metastases: the diagnostic value of computed tomography].
Steinkamp HJ; van der Hoeck E; Böck JC; Felix R
Rofo; 1999 May; 170(5):457-62. PubMed ID: 10370409
[TBL] [Abstract][Full Text] [Related]
30. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography detection of extracapsular spread of squamous cell carcinoma of the head and neck in metastatic cervical lymph nodes.
Carlton JA; Maxwell AW; Bauer LB; McElroy SM; Layfield LJ; Ahsan H; Agarwal A
Neuroradiol J; 2017 Jun; 30(3):222-229. PubMed ID: 28627989
[TBL] [Abstract][Full Text] [Related]
32. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and specificity of computed tomography for detection of extranodal spread from metastatic head and neck squamous cell carcinoma.
Souter MA; Allison RS; Clarkson JH; Cowan IA; Coates MH; Wells JE
J Laryngol Otol; 2009 Jul; 123(7):778-82. PubMed ID: 19134244
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
35. Effect of increasing the sampling interval to 2 seconds on the radiation dose and accuracy of CT perfusion of the head and neck.
Tawfik AM; Razek AA; Elhawary G; Batouty NM
J Comput Assist Tomogr; 2014; 38(3):469-73. PubMed ID: 24651742
[TBL] [Abstract][Full Text] [Related]
36. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
Velázquez RA; McGuff HS; Sycamore D; Miller FR
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):74-7. PubMed ID: 14732772
[TBL] [Abstract][Full Text] [Related]
37. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
[TBL] [Abstract][Full Text] [Related]
39. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
40. 64-row MDCT perfusion of head and neck squamous cell carcinoma: technical feasibility and quantitative analysis of perfusion parameters.
Faggioni L; Neri E; Cerri F; Picano E; Seccia V; Muscatello L; Franceschini SS; Bartolozzi C
Eur Radiol; 2011 Jan; 21(1):113-21. PubMed ID: 20652255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
